Pancreas transplantation in crossmatch-positive recipients

Clinical Transplantation

Volumn 17, Issue 3, 2003, Pages 242-248

  Khwaja, Khalid ^a   Wijkstrom, Martin ^a   Gruessner, Angelika ^a   Noreen, Harriet ^a   Sutherland, David E R ^a   Humar, Abhinav ^a   Kandaswamy, Raja ^a   Gruessner, Rainer W G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Pancreas transplantation; Plasmapheresis; Positive crossmatch; Rejection

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; TACROLIMUS;

ARTICLE; B LYMPHOCYTE; BLOOD GROUP TYPING; CLINICAL PROTOCOL; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DATA BASE; DEATH; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCUBATION TIME; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PANCREAS INSUFFICIENCY; PANCREAS TRANSPLANTATION; PANCREATITIS; PLASMAPHERESIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; REOPERATION; RISK ASSESSMENT; T LYMPHOCYTE; TREATMENT OUTCOME; VASCULAR DISEASE;

B-LYMPHOCYTES; COLD; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN PRESERVATION; PANCREAS TRANSPLANTATION; T-LYMPHOCYTES; TIME FACTORS;

EID: 0038678027     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00042.x     Document Type: Article

References (36)

1. Terasaki PI, Marchioro TL, Starzl TE. Sero-typing of human lymphocyte antigens: preliminary trials on longterm kidney homograft survivors. In: Russell PS, Winn HJ, Amos DB eds. Histocompatibility Testing. Washington DC National Academy of Sciences, Publication 1229,1965: 83.
2. Kissmeyer-Nielsen F, Olsen S, Peterse VP et al. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1996: 2: 662.
3. Williams GM, Hume DM, Hudson RP et al. 'Hyperacute' renal-homograft rejection in man. N Engl J Med 1968: 279: 611.
4. Cardella CJ. The use of the kidney with an historical positive, and current negative crossmatch. Pediatr Nephrol 1991: 5: 126.
5. The United Network for Organ Sharing. Bylaws - Standards for Histocompatibity testing. Richmond, VA, 2001. Retrieved April 16, 2002 from the World Wide Web: http://www.unos.org/about/policy-bylaws-appendixb-attachl.html.
6. Gruessner AC, Sutherland DER. Analysis of the International Pancreas Transplant Registry. In: Cecka JM, Terasaki PI eds. Clinical Transplants 2001. UCLA Immunogenetics Center, 2002: 41.
7. Sutherland DER, Gruessner RWG, Dunn DL et al. Lessons learned from more than 1,000 transplants at a single institution. Ann Surg 2001: 233: 463.
8. Kandaswamy R, Sutherland DE, Humar A, Payne WD, Gruessner RW, Matas AJ. Transplantation without a final crossmatch-it can be done. Transplant Proc 2001: 33: 1234.
9. Matas AJ, Humar A, Kandaswamy R, Payne WD, Gruessner RWG, Sutherland DER. Kidney and pancreas transplantation without a crossmatch in select circumstances - it can be done. Clin Transplant 2001: 15: 236.
10. Peltenburg HG, Tiebosch A, Van Den Berg-Loonen PM et al. A positive T cell crossmatch and accelerated acute rejection of a pancreas-spleen allograft. Transplantation 1991: 53: 226.
11. Noreen HJ. Crossmatch tests. In Mikaen A, Phelan DL, Mickelson EM. Ashi Laboratory Manual, 3rd edn. Lenexa, KS: The American Society for Histocompatibility and Immunogenetics, 1994: I.C.1.1.
12. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969: 280: 735.
13. Matas AJ, Tellis VA, Glicklich D et al. Transplantation with a past positive crossmatch and cyclosporine immunosuppression: a 5-year experience. Clin Transplant 1988: 2: 336.
14. Ten Hoor GM, Coopmans M, Allebes WA. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. Transplantation 1993: 56: 298.
15. Bryan CF, Shield CF, Warsady BA et al. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc 1999: 31: 225.
16. Leavey SF, Walshe JJ, O'Neill D et al. Renal transplantation performed across a positive crossmatch: a single center experience. Renal Transplant 1997: 166: 245.
17. Lobo PI, Westervelt FB, Rudolph LE. Kidney transplantability across a positive cross-match: cross-match assays and distribution of B lymphocytes in donor tissues. Lancet 1977: 1: 925.
18. Karuppan SS, Lindholm A, Moller E. Characterization and significance of donor-reactive B cell antibodies in current sera of kidney transplant patients. Transplantation 1990: 49: 510.
19. Jendrisak M, Phelan D, Marsh J et al. Significance of B-cell crossmatch on outcome in renal transplantation. Transplant Proc 1991: 23: 434.
20. Wang-Rodriguez J, Rearden A. Effect of crossmatching on outcome in organ transplantation. Crit Rev Clin Lab Sci 1995: 32: 345.
21. Takaya S, Bronsther O, Iwaki Y et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992: 53: 400.
22. Katz SM, Kimball PM, Ozaki C et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients. Transplantation 1994: 57: 616.
23. Dafoe DC, Bromberg JS, Grossman RA et al. Renal transplantation despite a positive crossmatch with and without prophylactic OKT3. Transplantation 1991: 51: 762.
24. Stratta RJ, Mason B, Lorentzen DF et al. Cadaveric renal transplantation with quadruple immunosuppression in patients with a positive antiglobulin crossmatch. Transplantation 1989: 47: 282.
25. Welsh KI, Bunce M. HLA typing, matching and cross-matching in renal transplantation. In: Morris PJ, ed. Kidney Transplantation - Principles and Practice. Philadelphia: W.B. Saunders Company, 2001: 135.
26. Garovoy MR, Rheinschmidt MA, Bigos M et al. Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation. Transplant Proc 1983: 15: 1939.
27. Iwaki Y, Cook DJ, Terasaki PI et al. Flow cytometry crossmatching in human cadaver transplantation. Transplant Proc 1987: 19: 764.
28. Lazda VA, Polack R, Moses MF, Jonasson O. The relationship between flow cytometry crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients. Transplantation 1988: 45: 562.
29. Chapman JR, Deierhoi MH, Carter NP, Ting A, Morris PJ. Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantation. Transplant Proc 1985: 17: 2480.
30. Welsh KI, Bunce M. New methods in tissue typing. In: Thiru S, Waldman H eds. Pathology and Immunology of Transplantation and Rejection. Oxford: Blackwell Science Ltd, 2001: 73.
31. Tyan DB, Li VA, Czer L et a]. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994: 57: 553.
32. Reisaeter AV, Leivestad T, Albrectsen D et al. Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients. Transplantation 1995: 60: 242.
33. Higgins RM, Bevan DJ, Carey BS et al. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation. Lancet 1996: 348: 1208.
34. Kupin WL, Venkat KK, Hayashi H et al. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients. Transplantation 1991: 51: 324.
35. Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into crossmatch-positive recipients. Transplantation 2000: 70: 887.
36. Jordan SC, Vo AA, Bunnapradist S, Tyan T. IVIG inhibits crossmatch positivity and allows successful transplantation in living-donor and cadaver transplant recipients. Am J Transplant 2002: 2 (Suppl. 3): 356.